Trials / No Longer Available
No Longer AvailableNCT03724227
Expanded Access for ACE-011
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to ACE-011.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACE-011 | ACE-011 will be administered subcutaneous injection |
Timeline
- First posted
- 2018-10-30
- Last updated
- 2020-07-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03724227. Inclusion in this directory is not an endorsement.